Brain-specific angiogenesis inhibitor 2 (BAI2) is a member of the adhesion G protein-coupled receptor (GPCR) family, characterized by their extensive N-terminal extracellular domains and their role in cell-cell interaction, adhesion, and sensing of the cellular environment. BAI2, in particular, has been implicated in the regulation of synaptic and neuronal functions, acting as a critical modulator in the central nervous system (CNS). Its activation is believed to contribute to various cellular processes including neurogenesis, synaptic plasticity, and the maintenance of neural networks. The functional mechanisms through which BAI2 exerts its effects are complex, involving the interaction with specific ligands, intracellular signaling cascades, and the modulation of cellular adhesion properties. This receptor operates through a distinct set of signaling pathways that are activated upon ligand binding, leading to the recruitment of downstream signaling molecules and the initiation of specific cellular responses.
The activation of BAI2 is mediated through several mechanisms, primarily through the binding of specific extracellular ligands that induce conformational changes in the receptor structure, facilitating interaction with G proteins and the subsequent activation of intracellular signaling pathways. This process can lead to the activation of second messenger systems, such as cyclic AMP (cAMP) or phospholipase C, which further propagate the signal through the cell to elicit specific cellular responses. Additionally, BAI2 activation can influence the actin cytoskeleton, promoting changes in cell morphology and adhesion properties, which are crucial for neuronal function and plasticity. The receptor's ability to interact with various intracellular proteins also suggests a role in the modulation of gene expression, further influencing cellular behavior and function. The specificity of BAI2's activation mechanisms highlights the receptor's role in finely tuning neuronal processes and underscores the complexity of signaling pathways involved in maintaining CNS homeostasis and function.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Forskolin | 66575-29-9 | sc-3562 sc-3562A sc-3562B sc-3562C sc-3562D | 5 mg 50 mg 1 g 2 g 5 g | $78.00 $153.00 $740.00 $1413.00 $2091.00 | 73 | |
Forskolin, by elevating cAMP levels, indirectly enhances BAI-2 activity. Elevated cAMP levels activate PKA, which can modulate GPCR signaling pathways, indirectly affecting BAI-2's role in synaptic plasticity and neurogenesis. | ||||||
(−)-Epigallocatechin Gallate | 989-51-5 | sc-200802 sc-200802A sc-200802B sc-200802C sc-200802D sc-200802E | 10 mg 50 mg 100 mg 500 mg 1 g 10 g | $43.00 $73.00 $126.00 $243.00 $530.00 $1259.00 | 11 | |
Epigallocatechin gallate, as a kinase inhibitor, may indirectly activate BAI-2 by inhibiting kinases that negatively regulate GPCR pathways, thereby potentially enhancing BAI-2's function in neuronal signaling. | ||||||
D-erythro-Sphingosine-1-phosphate | 26993-30-6 | sc-201383 sc-201383D sc-201383A sc-201383B sc-201383C | 1 mg 2 mg 5 mg 10 mg 25 mg | $165.00 $322.00 $570.00 $907.00 $1727.00 | 7 | |
Sphingosine-1-phosphate, through its receptor interactions, can indirectly enhance BAI-2 activity by modulating GPCR signaling pathways, influencing BAI-2's role in neuroprotection and inflammation. | ||||||
Dibutyryl-cAMP | 16980-89-5 | sc-201567 sc-201567A sc-201567B sc-201567C | 20 mg 100 mg 500 mg 10 g | $47.00 $136.00 $492.00 $4552.00 | 74 | |
Dibutyryl-cAMP, a cAMP analog, indirectly activates BAI-2 by elevating PKA activity, which can modulate GPCR-mediated signaling pathways, impacting BAI-2's involvement in synaptic modulation. | ||||||
Rolipram | 61413-54-5 | sc-3563 sc-3563A | 5 mg 50 mg | $77.00 $216.00 | 18 | |
Rolipram, a PDE4 inhibitor, raises cAMP levels, leading to PKA activation. This can indirectly support BAI-2 activity in GPCR-related signaling, affecting neuronal communication. | ||||||
IBMX | 28822-58-4 | sc-201188 sc-201188B sc-201188A | 200 mg 500 mg 1 g | $260.00 $350.00 $500.00 | 34 | |
IBMX, a nonspecific inhibitor of phosphodiesterases, increases cAMP levels, leading to PKA activation. This indirectly supports BAI-2's role in GPCR-mediated neuronal signaling. | ||||||
Curcumin | 458-37-7 | sc-200509 sc-200509A sc-200509B sc-200509C sc-200509D sc-200509F sc-200509E | 1 g 5 g 25 g 100 g 250 g 1 kg 2.5 kg | $37.00 $69.00 $109.00 $218.00 $239.00 $879.00 $1968.00 | 47 | |
Curcumin can indirectly enhance BAI-2 activity by modulating various signaling pathways and transcription factors that interact with GPCR signaling, impacting BAI-2's neuronal functions. | ||||||
Lithium | 7439-93-2 | sc-252954 | 50 g | $214.00 | ||
Lithium Carbonate can indirectly enhance BAI-2's function by affecting GSK-3β and other pathways involved in GPCR signaling. | ||||||
PGE2 | 363-24-6 | sc-201225 sc-201225C sc-201225A sc-201225B | 1 mg 5 mg 10 mg 50 mg | $57.00 $159.00 $275.00 $678.00 | 37 | |
Prostaglandin E2, through its receptor interactions, may indirectly enhance BAI-2 activity by influencing GPCR signaling pathways, which are integral to BAI-2's role in neuroinflammation and repair. | ||||||
N-Acetyl-L-cysteine | 616-91-1 | sc-202232 sc-202232A sc-202232C sc-202232B | 5 g 25 g 1 kg 100 g | $34.00 $74.00 $270.00 $114.00 | 34 | |
N-Acetyl cysteine, an antioxidant, may indirectly enhance BAI-2 activity by reducing oxidative stress, thereby influencing GPCR-mediated signaling pathways relevant to BAI-2's role in neuronal health. | ||||||